Bilirubin Blood Test Market Forecast Highlights A $2.08 Billion Opportunity For Industry Participants
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Bilirubin Blood Test Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The bilirubin blood test market size has experienced robust growth over recent years. It is anticipated to expand from $1.46 billion in 2025 to $1.57 billion in 2026, registering a compound annual growth rate (CAGR) of 7.4%. This historical expansion can be linked to several factors, including the increase in neonatal jaundice screening programs, a rise in hospital-based liver function testing, enhanced diagnostic awareness of liver disorders, the regular integration of serum bilirubin testing into clinical practice, and the broader availability of pediatric and infant diagnostic services.
The bilirubin blood test market is anticipated to experience substantial growth in the upcoming years, projected to reach $2.08 billion in 2030 with a compound annual growth rate (CAGR) of 7.3%. This expansion during the forecast period is primarily driven by the increasing incidence of chronic liver disease and hepatitis, a heightened need for early assessment of liver health, and the growing application of bilirubin testing in primary care environments. Additionally, higher rates of testing among aging and at-risk patient groups, coupled with the advancement of point-of-care and specialized liver diagnostics, contribute to this trajectory. Major developments expected in this period include the wider use of bilirubin testing for evaluating liver function, its increasing adoption in screening for neonatal jaundice, and a rising demand for such tests in hematology and for preliminary liver disorder assessments. Furthermore, there will be an expansion of bilirubin monitoring across various hospital and clinical settings, emphasizing proactive detection and routine screening for maintaining liver health.
Get A Free Sample Report With In-Depth Market Insights:
Bilirubin Blood Test Market Development Factors: What’s Supporting Demand?
The increasing occurrence of liver conditions is anticipated to drive expansion in the bilirubin blood test market moving forward. Liver ailments encompass various conditions that hinder the liver’s proper functioning, potentially stemming from factors like infections, excessive alcohol consumption, or metabolic issues. The surge in liver disease cases is linked to higher rates of obesity, heavy alcohol intake, viral pathogens, and poor lifestyle decisions, all of which contribute to liver impairment and harm. Liver conditions can markedly affect the body’s bilirubin levels, with bilirubin blood tests assisting in diagnosing and tracking liver function. These tests offer vital information about patient health and support healthcare professionals in efficiently addressing and treating liver-associated issues. For example, data from GOV.UK, a UK department for science, innovation, and technology, showed that in April 2023, hospital admission rates for liver disease climbed from 150.6 (148.2–152.9) to 155.2 (152.9–157.5) per 100,000 population between the fiscal years concluding 2022 and 2023, highlighting a persistent rise in hospitalizations due to liver conditions. Consequently, the increasing prevalence of liver ailments is stimulating the bilirubin blood test market.
Bilirubin Blood Test Market Segment Analysis And Revenue Potential
The bilirubin blood test market covered in this report is segmented –
1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test
2) By Age Group: Adults, Pediatrics, Infants
3) By Application: Hospital, Clinic, Other Applications
Subsegments:
1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection
2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert’s Syndrome Detection, Monitoring For Preliver Conditions
3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment
Bilirubin Blood Test Market Transformation Trends: What Innovations Are Driving Change?
Companies operating within the bilirubin blood test market are increasingly adopting strategic partnership approaches to expand their reach and enhance their service offerings. Such a strategic partnership typically denotes a collaborative relationship between two or more organizations that merge their resources, expertise, and efforts to achieve common goals or objectives. For instance, in December 2023, Calmark Sweden AB, an Israel-based company specializing in medical diagnostic biotechnology solutions, finalized an exclusive distributor agreement with Techno Orbits in Saudi Arabia for Calmark’s bilirubin test specifically designed for newborns. Techno Orbits will manage the distribution and sales of this product, leveraging its existing network and relationships, including those with the Ministry of Health. This alliance aims to facilitate the introduction of Calmark’s bilirubin test into the Saudi market, where regulatory registration is projected to take between 3 to 6 months.
Bilirubin Blood Test Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the bilirubin blood test market are Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann‑La Roche Ltd, Siemens Healthineers, Danaher Corporation, Sysmex Corporation, Bio‑Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Mindray Medical International Limited, Randox Laboratories Ltd, bioMérieux SA, DiaSorin S.p.A, Horiba Ltd, ELITech Group SAS, Erba Mannheim, Hitachi High‑Technologies, DIRUI Industrial Co Ltd, Agappe Diagnostics, Awareness Technology Inc, Sekisui Diagnostics
View The Full Bilirubin Blood Test Market Report:
Bilirubin Blood Test Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the bilirubin blood test market in 2025. The regions covered in the bilirubin blood test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
